Post Carotid Stenting Cerebral Hyperperfusion: a Preventable Complication

This syndrome, which can be reverted, is also one of the causes of preventable stroke, at least in the context of carotid endarterectomy. At present, there is little information on the incidence of this condition in the context of carotid stenting, which is the purpose of this study, in addition to providing tips to prevent it.

Síndrome de Hiperperfusión cerebral post-angioplastia carotídea: una complicación prevenibleA systematic search resulted in 33 studies with a total 8731 carotid stenting procedures reporting 4.6% hyperperfusion risk (3.1 to 6.8%). Nearly half of hyperperfusion patients later had a stroke (47%), and more than half of strokes resulted fatal or disabling (54%).

 

Symptoms did not appear immediately after procedure, but at average 12 hours after procedure (8 to 36 hour range). This is clearly different form embolic stroke, also diagnosed in the same cath lab.


Read also: Far from a Being a Pun, Malnutrition Tips the Scales in TAVR.


Impaired cerebrovascular reserve was associated to higher risk of post stenting hyperperfusion syndrome (RR 5.18; CI 95% 1.0 to 26.8; p=0.049).

 

If the procedure takes place in the context of a symptomatic patient, the risk of periprocedural stroke is a lot higher ─this we have known for some time now. What we did not know is that evolution with hyperperfusion syndrome involves significantly lower risk of stroke compared to acute patients (RR 0.20; IC 95% 0.07 to 0.59; p=0.001).


Read also: Cost-Effectiveness of Frenestrated or Branched Endoprostheses vs. Open Surgery.


Patients with bilateral carotid stenosis or very critical lesions should be watched closely in the first hours after procedure, and their blood pressure needs to be monitored obsessively.

 

Conclusion

Cerebral hyperperfusion syndrome is relatively frequent and serious in patients undergoing carotid stenting, and it appears in the first hours after procedure, never immediately. We should encourage further research to find out how to treat this phenomenon, and also how to control blood pressure and measure cerebral blood flow.

 

Original title: Cerebral Hyperperfusion Syndrome After Carotid Artery Stenting: A Systematic Review and Meta-analysis.

Reference: Anne E. Huibers et al. Eur J Vasc Endovasc Surg (2018). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...